Drug
Birch triterpenes clinical trials
- studies test it
- 8
- open now
- 2
- in phase 3
- 3
- first study started
- 2008
Keep track of what changes. Save the birch triterpenes studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
8 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 5
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 2
Birken AG (4) · Memorial Sloan Kettering Cancer Center (1) · Amryt Research Limited (1) · Stanford University (1) · Chiesi Farmaceutici S.p.A. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses birch triterpenes is read from its arms, and is right about nine times in ten.
Testing it · 8
- Filsuvez in Moderate-to-Severe Epidermolysis Bullosa SimplexNot yet recruitingPhase 2Stanford UniversityNCT07756138Written as Filsuvez
- A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis BullosaRecruitingPhase 3Chiesi Farmaceutici S.p.A.NCT06917690Written as Oleogel-S10
- A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast CancerCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT05190770Written as Oleogel-S10
- Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis BullosaCompletedPhase 3Amryt Research LimitedNCT03068780Written as Oleogel-S10
- Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10)CompletedPhase 2Birken AGNCT01294241Written as Oleogel-S10
- Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn WoundsCompletedPhase 3Birken AGNCT01657292Written as Oleogel-S10 ointment
- The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic KeratosesCompletedPhase 2Birken AGNCT00786994Written as Oleogel-S10 100 mg/g
- Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor SitesCompletedPhase 2Birken AGNCT01294254Written as Oleogel-S10
Codes
What other systems call birch triterpenes · ClinicalTrials.gg INT002173
- MeSH (NLM) C000731943birch triterpenesOne source NLM
- UNII (FDA) BX09B0RQR0BIRCH TRITERPENESConfirmed FDA, NLM
- NCI Thesaurus C177079Birch TriterpenesOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000731943 | birch triterpenes | One source NLM |
| UNII (FDA) | BX09B0RQR0 | BIRCH TRITERPENES | Confirmed FDA, NLM |
| NCI Thesaurus | C177079 | Birch Triterpenes | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.